QS vs. AVDL

Last updated Jun 9, 2026

QS (QuantumScape Corporation) and AVDL (Avadel Pharmaceuticals plc) are both stocks. QS operates in Auto Parts (Consumer Cyclical), while AVDL operates in Drug Manufacturers - Specialty & Generic (Healthcare). At a 0.21 correlation, their price movements are largely independent.

Performance

QS vs. AVDL - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in QuantumScape Corporation (QS) and Avadel Pharmaceuticals plc (AVDL). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

QS

• 1D: -0.13%
• 1M: 1.59%
• YTD: -26.49%
• 6M: -39.21%
• 1Y: 85.47%
• 3Y*: 6.73%
• 5Y*: -24.41%
• 10Y*: —

AVDL

• 1D: —
• 1M: —
• YTD: —
• 6M: —
• 1Y: —
• 3Y*: —
• 5Y*: —
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

QS vs. AVDL - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020
QS QuantumScape Corporation	-26.49%	100.77%	-25.32%	22.57%	-74.45%	-73.72%	757.36%
AVDL Avadel Pharmaceuticals plc	0.42%	105.04%	-25.57%	97.21%	-11.39%	20.96%	-15.55%

Correlation

The correlation between QS and AVDL is 0.09, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.09
Correlation (3Y) Calculated over the trailing 3-year period	0.16
Correlation (5Y) Calculated over the trailing 5-year period	0.21
Correlation (All Time) Calculated using the full available price history since Aug 17, 2020	0.21

The correlation between QS and AVDL shifts across timeframes, from 0.09 (1 year) to 0.21 (5 years), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap QS : $4.68B AVDL : $2.19B
EPS QS : -$0.72 AVDL : -$0.00
PB Ratio QS : 4.22 AVDL : 22.31
Total Revenue (TTM) QS : $0.00 AVDL : $248.52M
Gross Profit (TTM) QS : -$49.03M AVDL : $234.76M
EBITDA (TTM) QS : -$378.92M AVDL : $10.13M

Return for Risk

QS vs. AVDL — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

QS

QS Risk / Return Rank: 69
QS Sharpe Ratio Rank: 69
QS Sortino Ratio Rank: 75
QS Omega Ratio Rank: 71
QS Calmar Ratio Rank: 67
QS Martin Ratio Rank: 61

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

QS vs. AVDL - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for QuantumScape Corporation (QS) and Avadel Pharmaceuticals plc (AVDL). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	QS	AVDL	Difference
Sharpe ratio: Return per unit of total volatility	0.83	—	—
Sortino ratio: Return per unit of downside risk	1.93	—	—
Omega ratio: Gain probability vs. loss probability	1.23	—	—
Calmar ratio: Return relative to maximum drawdown	1.27	—	—
Martin ratio: Return relative to average drawdown	2.00	—	—
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

Sharpe Ratios by Period

	QS	AVDL	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	0.83	—	—
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	-0.29	—	—
Sharpe Ratio (All Time) Calculated using the full available price history	-0.04	—	—

Drawdowns

Drawdown Indicators

	QS	AVDL	Difference
Max Drawdown Largest peak-to-trough decline	-97.36%	—	—
Max Drawdown (1Y) Largest decline over 1 year	-67.68%	—	—
Max Drawdown (3Y) Largest decline over 3 years	-73.93%	—	—
Max Drawdown (5Y) Largest decline over 5 years	-91.45%	—	—
Current Drawdown Current decline from peak	-94.18%	—	—
Average Drawdown Average peak-to-trough decline	-85.55%	—	—
Ulcer Index Depth and duration of drawdowns from previous peaks	42.96%	—	—

Volatility

Volatility by Period

	QS	AVDL	Difference
Volatility (1M) Calculated over the trailing 1-month period	26.40%	—	—
Volatility (6M) Calculated over the trailing 6-month period	48.57%	—	—
Volatility (1Y) Calculated over the trailing 1-year period	103.45%	—	—
Volatility (5Y) Calculated over the trailing 5-year period, annualized	85.88%	—	—
Volatility (10Y) Calculated over the trailing 10-year period, annualized	106.01%	—	—

Dividends

QS vs. AVDL - Dividend Comparison

Neither QS nor AVDL has paid dividends to shareholders.

Tickers have no history of dividend payments

Financials

Frequently Asked Questions

Can I hold both QS and AVDL in my portfolio?

QS and AVDL have a correlation of 0.09, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.